Evidence map›Paper›PMID 24014508›Full record

ReviewJournal of child neurology2013

Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease).

Heather R Adams, Jonathan W Mink, University of Rochester Batten Center Study Group

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of child neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03770572 (Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03770572 phase1 / phase2active not recruitingnot on this mapstarted 2018, after this paper: background citation

Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9

TypeinterventionalSponsorNeela TherapeuticsRan2018 to 2029Enrolled7ConditionsCLN3, Batten DiseaseArmsLow dose CLN-301, High dose CLN-301
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Brain proton MR spectroscopy measurements in CLN3 disease.Molecular genetics and metabolism · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Heather R AdamsUniversity of Rochester Batten Center Study Group, University of Rochester School of Medicine and Dentistry, Department of Neurology, Rochester, New York, NY, USA.
Jonathan W Mink
University of Rochester Batten Center Study Group

Funding

Training & EducationU54NS065768 · NINDS · UNIVERSITY OF MINNESOTA · PI WHITLEY, CHESTER B. · 2009 to 2024
$17.7M
Clinical and Neuropsychological Investigations in Batten DiseaseR01NS060022 · NINDS · UNIVERSITY OF ROCHESTER · PI MINK, JONATHAN W. · 2007 to 2010
$1.2M
Neurobehavioral Outcomes of Degenerative Neurologic Disease in ChildhoodK23NS058756 · NINDS · UNIVERSITY OF ROCHESTER · PI ADAMS, HEATHER · 2008 to 2012
$602k
NINDS NIH HHS 5K23 NS058756NINDS NIH HHS 5R01NS060022NINDS NIH HHS 5U54NS065768NINDS NIH HHS K23 NS058756NINDS NIH HHS R01 NS060022NINDS NIH HHS U54 NS065768
6 · The paper itself

Abstract

Juvenile neuronal ceroid lipofuscinosis is a childhood-onset neurodegenerative disease with prominent symptoms comprising a pediatric dementia syndrome: intellectual decline, mood and behavioral impairments, and loss of adaptive skills. We review the history of neurobehavioral features in juvenile neuronal ceroid lipofuscinosis and the work of the University of Rochester Batten Center to characterize the extent and progression of neurobehavioral symptoms over the disease course, and discuss the relevance of neurobehavioral studies as an aid to understanding the clinical phenotype of juvenile Batten disease and potential targets for intervention.

Indexed as

ChildChild Behavior DisordersCognition DisordersDisease ProgressionHumansNeuronal Ceroid-LipofuscinosesPhenotypebehaviorcognitionneuropsychologyquality of lifeUnified Batten Disease Rating Scale

Identifiers

PMID24014508
PMCPMC3976549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.